Abstract |
A novel library of coumarin tagged 1,3,4 oxadiazole conjugates was synthesized and evaluated for their antiproliferative activities against MDA-MB-231 and MCF-7 breast cancer cell lines. The evaluation studies revealed that compound 9d was the most potent molecule with an IC50 value of <5 µM against the MCF-7 cell line. Interestingly, compounds 10b and 11a showed a similar trend with lower inhibitory concentration (IC50 = 7.07 µM), in Estrogen Negative (ER-) cells than Estrogen Positive (ER+) cells. Structure-activity relationship (SAR) studies revealed that conjugates bearing benzyl moieties (9b, 9c and 9d) had superior activities compared to their alkyl analogues. The most potent compound 9d showed ∼1.4 times more potent activity than tamoxifen against MCF-7 cell line; while the introduction of sulfone unit in compounds 11a, 11b and 11c resulted in significant cytotoxicity against both MCF-7 and MDA-MB-231 cell lines. These results were further supported by docking studies, which revealed that the stronger binding affinity of the synthesized conjugates is due to the presence of sulfone unit attached to the substituted benzyl moiety in their pharmacophores.
|
Authors | Sanjeev Dhawan, Nagaraju Kerru, Paul Awolade, Ashona Singh-Pillay, Sourav Taru Saha, Mandeep Kaur, Sreekantha B Jonnalagadda, Parvesh Singh |
Journal | Bioorganic & medicinal chemistry
(Bioorg Med Chem)
Vol. 26
Issue 21
Pg. 5612-5623
(11 15 2018)
ISSN: 1464-3391 [Electronic] England |
PMID | 30360952
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2018 Elsevier Ltd. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Coumarins
- Estrogen Receptor alpha
- Oxadiazoles
- ErbB Receptors
|
Topics |
- Antineoplastic Agents
(chemical synthesis, chemistry, pharmacology)
- Cell Line, Tumor
- Coumarins
(chemical synthesis, chemistry, pharmacology)
- ErbB Receptors
(chemistry)
- Estrogen Receptor alpha
(chemistry)
- Humans
- Molecular Docking Simulation
- Molecular Structure
- Oxadiazoles
(chemical synthesis, chemistry, pharmacology)
- Structure-Activity Relationship
|